Human memory B cells producing potent cross-neutralizing antibodies against human parechovirus; implications for prevalence, treatment and diagnosis

作者: B. M. Westerhuis , K. S. M. Benschop , G. Koen , Y. B. Claassen , K. Wagner

DOI: 10.1128/JVI.01079-15

关键词:

摘要: UNLABELLED The family Picornaviridae is a large and diverse group of positive-sense RNA viruses, including human enteroviruses (EVs) parechoviruses (HPeVs). immune response against EVs HPeVs thought to be mainly humoral, an insufficient neutralizing antibody (Ab) during infection risk factor can ultimately life threatening. accessibility different antigenic sites observed cross-reactivity make good target for development therapeutic monoclonal antibodies (MAbs). In this study, we generated two MAbs specific HPeV by screening culture supernatants Ab-producing B cell cultures direct neutralization HPeV1. Both showed HPeV1-specific as well HPeV2. One antibody, AM18, cross-neutralized HPeV4, -5, -6 coxsackievirus A9 (CV-A9). VP1 capsid protein-specific assays confirmed that AM18 bound HPeV1, -2, -4 with high affinity (11.5 pM). contrast, the MAb AM28, which neutralized HPeV1 even more efficiently than did no HPeV3 or other not bind any proteins, suggesting AM28 conformation-dependent, nonlinear epitope on virus. discovery are cross-reactive between may help treatment options vaccine design based epitopes recognized these antibodies. IMPORTANCE infections widespread among young children adults, causing broad range disease. Infections severe threatening, while antiviral available. Given absence Abs disease in infants, picornavirus would option. To study detail, MAbs. show also HPeVs. Surprisingly, CV-A9. These provide unique tool further research diagnosis (antigen detection) possible infections.

参考文章(56)
Zhiwei Che, Norman H Olson, Donna Leippe, Wai-ming Lee, Anne G Mosser, Roland R Rueckert, Timothy S Baker, Thomas J Smith, None, Antibody-Mediated Neutralization of Human Rhinovirus 14 Explored by Means of Cryoelectron Microscopy and X-Ray Crystallography of Virus-Fab Complexes Journal of Virology. ,vol. 72, pp. 4610- 4622 ,(1998) , 10.1128/JVI.72.6.4610-4622.1998
P J Hughes, C Horsnell, T Hyypiä, G Stanway, The Coxsackievirus A9 RGD Motif Is Not Essential for Virus Viability Journal of Virology. ,vol. 69, pp. 8035- 8040 ,(1995) , 10.1128/JVI.69.12.8035-8040.1995
E A Emini, P Ostapchuk, E Wimmer, Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization. Journal of Virology. ,vol. 48, pp. 547- 550 ,(1983) , 10.1128/JVI.48.2.547-550.1983
J.G. Wildenbeest, J.G. Wildenbeest, K.S.M. Benschop, R.P. Minnaar, S. Bouma-de Jongh, K.C. Wolthers, D. Pajkrt, K.S.M. Benschop, R.P. Minnaar, S. Bouma-de Jongh, K.C. Wolthers, D. Pajkrt, Clinical relevance of positive human parechovirus type 1 and 3 PCR in stool samples Clinical Microbiology and Infection. ,vol. 20, ,(2014) , 10.1111/1469-0691.12542
G Stanway, N Kalkkinen, M Roivainen, F Ghazi, M Khan, M Smyth, O Meurman, T Hyypiä, Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. Journal of Virology. ,vol. 68, pp. 8232- 8238 ,(1994) , 10.1128/JVI.68.12.8232-8238.1994
Brenda Westerhuis, Pekka Kolehmainen, Kimberley Benschop, Noora Nurminen, Gerrit Koen, Marjaleena Koskiniemi, Olli Simell, Mikael Knip, Heikki Hyöty, Katja Wolthers, Sisko Tauriainen, Human parechovirus seroprevalence in Finland and the Netherlands Journal of Clinical Virology. ,vol. 58, pp. 211- 215 ,(2013) , 10.1016/J.JCV.2013.06.036
A. Alho, J. Marttila, J. Ilonen, T. Hyypia, Diagnostic Potential of Parechovirus Capsid Proteins Journal of Clinical Microbiology. ,vol. 41, pp. 2294- 2299 ,(2003) , 10.1128/JCM.41.6.2294-2299.2003
Karita Sadeharju, Mikael Knip, Suvi M Virtanen, Erkki Savilahti, Sisko Tauriainen, Pentti Koskela, Hans K Akerblom, Heikki Hyoty, Finnish TRIGR Study Group, Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics. ,vol. 119, pp. 941- 946 ,(2007) , 10.1542/PEDS.2006-0780
Thomas J Smith, Elaine S Chase, Timothy J Schmidt, Norman H Olson, Timothy S Baker, None, Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature. ,vol. 383, pp. 350- 354 ,(1996) , 10.1038/383350A0
Timo Pulli, Hilkka Lankinen, Merja Roivainen, Timo Hyypiä, Antigenic sites of coxsackievirus A9. Virology. ,vol. 240, pp. 202- 212 ,(1998) , 10.1006/VIRO.1997.8908